Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Cannabis Suisse (CSUI) EBIT (2016 - 2026)

Cannabis Suisse has reported EBIT over the past 11 years, most recently at -$69394.0 for Q1 2026.

  • Quarterly EBIT fell 3.9% to -$69394.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$282986.0 through Feb 2026, up 10.64% year-over-year, with the annual reading at -$288013.0 for FY2025, 12.09% down from the prior year.
  • EBIT was -$69394.0 for Q1 2026 at Cannabis Suisse, up from -$74980.0 in the prior quarter.
  • Over five years, EBIT peaked at -$22766.0 in Q2 2022 and troughed at -$156052.0 in Q1 2023.
  • The 5-year median for EBIT is -$66788.0 (2025), against an average of -$69437.1.
  • Year-over-year, EBIT skyrocketed 96.63% in 2022 and then tumbled 279.47% in 2023.
  • A 5-year view of EBIT shows it stood at -$29375.0 in 2022, then tumbled by 72.6% to -$50702.0 in 2023, then plummeted by 82.06% to -$92309.0 in 2024, then grew by 18.77% to -$74980.0 in 2025, then rose by 7.45% to -$69394.0 in 2026.
  • Per Business Quant, the three most recent readings for CSUI's EBIT are -$69394.0 (Q1 2026), -$74980.0 (Q4 2025), and -$84535.0 (Q3 2025).